BioRad Laboratories
Open
$290.45
Prev. Close
$290.42
High
$291.01
Low
$290.12
Market Snapshot
$7.83B
46.4
-64.90
$2.57B
Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. The company is headquartered in Hercules, California and currently employs 7,450 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
BioRad Laboratories is not directly mentioned in the provided headlines; no specific news regarding BioRad Laboratories can be summarized from this information.
Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. The company is headquartered in Hercules, California and currently employs 7,450 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Recently from Cashu

BioRad Laboratories Secures MicroVal Approval for Enhanced Food Safety Testing Solutions
BioRad Laboratories (Ticker: BIO) enhances its credibility in the food safety sector with the recent MicroVal approval of its EZ-Check Listeria spp. and Listeria monocytogenes detection kits. This val…
VST BIO Corporation Secures $45 Million to Advance Stroke Therapeutics Development
VST BIO Corporation's Series A Financing Fuels Stroke Therapeutics Development VST BIO Corporation, a San Diego-based biotechnology firm specializing in stroke therapeutics, successfully secures $45 m…
Halia Therapeutics to Unveil Novel Inflammasome Inhibitors at BIO Investment & Growth Summit
Innovative Focus on Inflammasome Inhibition: Halia Therapeutics Sets the Stage at BIO Summit Halia Therapeutics prepares to captivate the biopharmaceutical community with its upcoming presentation at…
Halia Therapeutics to Present Novel Inflammation Treatments at BIO Investment & Growth Summit
Halia Therapeutics Set to Showcase Innovative Approaches to Inflammation at Upcoming Summit Halia Therapeutics, a promising player in the biopharmaceutical sector, plans to present its strategic visio…